Fig. 2From: Does the cytokine adsorber CytoSorb® reduce vancomycin exposure in critically ill patients with sepsis or septic shock? a prospective observational studyGoodness-of-fit plots for the final population pharmacokinetic model of vancomycin in critically ill patients undergoing renal replacement therapy and CytoSorb® therapy. Points: observations, lines: line of unityBack to article page